UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2026
Check Point Software Technologies
CHKP
$13.8B
| $958K | ﹤0.01% |
4,628
-1,278,363
| -100% | -$258M |
2013 Q2
49 quarters
|
|
2027
Scholastic
SCHL
$723M
| $957K | ﹤0.01% |
34,956
-27,536
| -44% | -$681K |
2013 Q2
49 quarters
|
|
2028
Marcus Corp
MCS
$846M
| $957K | ﹤0.01% |
61,698
-36,600
| -37% | -$587K |
2023 Q1
10 quarters
|
|
2029
Dream Finders Homes
DFH
$823M
| $949K | ﹤0.01% |
36,609
-34,865
| -49% | -$958K |
2022 Q4
11 quarters
|
|
2030
LendingTree
TREE
$350M
| $948K | ﹤0.01% |
14,641
-15,329
| -51% | -$884K |
2024 Q3
4 quarters
|
|
2031
iShares MSCI Turkey ETF
TUR
$162M
| $945K | ﹤0.01% |
+27,601
| New | +$939K |
2025 Q3
0 quarters
|
|
2032
FinVolution Group
FINV
$701M
| $941K | ﹤0.01% |
127,744
-160,500
| -56% | -$1.41M |
2021 Q2
17 quarters
|
|
2033
Amerant Bancorp
AMTB
$1.14B
| $941K | ﹤0.01% |
48,836
-36,576
| -43% | -$737K |
2023 Q1
10 quarters
|
|
2034
LandBridge Co
LB
$2.61B
| $939K | ﹤0.01% |
17,606
-19,233
| -52% | -$1.06M |
2024 Q4
3 quarters
|
|
2035
ICICI Bank
IBN
$101B
| $930K | ﹤0.01% |
30,762
-117,382
| -79% | -$3.83M |
2024 Q2
5 quarters
|
|
2036
Metallus
MTUS
$846M
| $924K | ﹤0.01% |
55,891
-60,932
| -52% | -$994K |
2022 Q2
13 quarters
|
|
2037
John B. Sanfilippo & Son
JBSS
$786M
| $912K | ﹤0.01% |
14,183
-10,898
| -43% | -$706K |
2017 Q3
32 quarters
|
|
2038
Nurix Therapeutics
NRIX
$2.29B
| $907K | ﹤0.01% |
98,145
-133,910
| -58% | -$1.39M |
2024 Q2
5 quarters
|
|
2039
Old Second Bancorp
OSBC
$1.27B
| $899K | ﹤0.01% |
52,022
-75,919
| -59% | -$1.37M |
2022 Q3
12 quarters
|
|
2040
Figure Technology Solutions
FIGR
$6.41B
| $898K | ﹤0.01% |
+24,700
| New | +$959K |
2025 Q3
0 quarters
|
|
2041
CEVA Inc
CEVA
$898M
| $895K | ﹤0.01% |
33,879
-26,161
| -44% | -$609K |
2020 Q2
21 quarters
|
|
2042
Akebia Therapeutics
AKBA
$222M
| $893K | ﹤0.01% |
326,959
+299,654
| +1,097% | +$997K |
2025 Q2
1 quarter
|
|
2043
Farmland Partners
FPI
$459M
| $891K | ﹤0.01% |
81,853
+49,965
| +157% | +$547K |
2022 Q3
12 quarters
|
|
2044
Gold.com Inc
GOLD
$1.16B
| $887K | ﹤0.01% |
34,271
-41,977
| -55% | -$993K |
2022 Q1
14 quarters
|
|
2045
Transcat
TRNS
$804M
| $881K | ﹤0.01% |
12,039
-12,713
| -51% | -$1.02M |
2022 Q4
11 quarters
|
|
2046
Donegal Group Class A
DGICA
$677M
| $879K | ﹤0.01% |
45,327
-31,678
| -41% | -$579K |
2022 Q4
11 quarters
|
|
2047
DELISTED
Golden Entertainment
GDEN
| $879K | ﹤0.01% |
37,259
-34,269
| -48% | -$912K |
2021 Q2
17 quarters
|
|
2048
iRadimed
IRMD
$1.14B
| $874K | ﹤0.01% |
12,280
-13,796
| -53% | -$919K |
2024 Q2
5 quarters
|
|
2049
Alexander's
ALX
$1.24B
| $872K | ﹤0.01% |
3,717
+2,155
| +138% | +$506K |
2024 Q2
5 quarters
|
|
2050
DELISTED
Mister Car Wash
MCW
| $867K | ﹤0.01% |
162,585
-90,519
| -36% | -$534K |
2023 Q1
10 quarters
|
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.